Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK) is a medical device company focused on developing innovative, minimally invasive catheter technologies for various therapeutic applications. The company aims to enhance procedural outcomes and patient safety through precision-engineered products designed for cardiovascular and other clinical interventions.
Company News
Catheter Precision has signed a strategic distribution agreement with FuMedica AG to introduce its LockeT suture retention device to hospitals and clinics across Switzerland, marking an important step in the company's European expansion strategy.
Catheter Precision, Inc. (VTAK) announced a 1-for-10 reverse stock split to increase its per-share trading price and meet NYSE American listing requirements. The company also reduced its authorized common stock and expanded its equity incentive plan.
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates. Adjusted EPS was $2.42 compared to $2.18 in prior-year quarter, beating the consensus of $2.31. For FY24, MMM sees adjusted sales growth of 0.25% to 2.25% and ad...